Get started
Author

Anne Davis‐Karim

Observed names: A. Davis-Karim, Anne Davis-Karim, Anne Davis-karim, Ruby Davis
Observed institutions: United States Department of Veterans Affairs, Baylor College of Medicine, University of Washington, Veterans Health Administration, Newcastle upon Tyne Hospitals NHS Foundation Trust, VA Office of Research and Development, Baylor University Medical Center, University of California System, University of California San Diego, VA North Texas Health Care System, Raymond G. Murphy VA Medical Center, VA Northwest Network, VA Long Beach Healthcare System, New Mexico VA Health Care System, Baylor Scott & White Health, The University of Texas Southwestern Medical Center
ORCID: 0000-0002-2801-3909
Observed ORCID: 0000-0002-2801-3909
OpenAlex ID: A5045625916
Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans
2018 · Murray A. Raskind, Elaine R. Peskind, et al. · New England Journal of Medicine · 340
PDF
Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn
2019 · Stuart J. Spechler, John G. Hunter, et al. · New England Journal of Medicine · 272
PDF
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia
2022 · G. Umberto Meduri, Mei-Chiung Shih, et al. · Intensive Care Medicine · 220
PDF
Effect of Repetitive Transcranial Magnetic Stimulation on Treatment-Resistant Major Depression in US Veterans
2018 · Jerome A. Yesavage, J. Kaci Fairchild, et al. · JAMA Psychiatry · 164
PDF
Comparative Effectiveness of Allopurinol and Febuxostat in Gout Management
2022 · James R. O’Dell, Mary T. Brophy, et al. · NEJM Evidence · 103
The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60
PDF
A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection
2024 · Dimitri M Drekonja, Aasma Shaukat, et al. · Clinical Infectious Diseases · 41
Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19
2022 · ACTIV-3/TICO Study Group*, Christina Barkauskas, et al. · Annals of Internal Medicine · 31
PDF
Design and Rationale for the Veterans Affairs “Cooperative Study Program 594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat” Trial
2018 · S. Timilsina, K. Brittan, et al. · Contemporary Clinical Trials · 24
Determinants of Achieving Serum Urate Goal with Treat‐to‐Target Urate‐Lowering Therapy in Gout
2023 · Lindsay N. Helget, James R. O'Dell, et al. · Arthritis & Rheumatology · 22
PDF
Efficacy and Safety of Allopurinol and Febuxostat in Patients With Gout and CKD: Subgroup Analysis of the STOP Gout Trial
2024 · Lindsay N. Helget, Anne Davis-Karim, et al. · American Journal of Kidney Diseases · 19
Intravenous aviptadil and remdesivir for treatment of COVID-19-associated hypoxaemic respiratory failure in the USA (TESICO): a randomised, placebo-controlled trial
2023 · Samuel M Brown, Christina E Barkauskas, et al. · The Lancet Respiratory Medicine · 19
PDF
Repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depression (TRMD) Veteran patients: study protocol for a randomized controlled trial
2017 · Zhibao Mi, Kousick Biswas, et al. · Trials · 19
PDF
Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19
2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15
PDF
Comparison of Gout Flares With the Initiation of Treat‐to‐Target Allopurinol and Febuxostat: A Post‐Hoc Analysis of a Randomized Multicenter Trial
2024 · Austin Barry, Lindsay N. Helget, et al. · Arthritis & Rheumatology · 13
PDF
Microbiota or placebo after antimicrobial therapy for recurrent Clostridioides difficile at home: A clinical trial with novel home-based enrollment
2021 · Dimitri M Drekonja, Aasma Shaukat, et al. · Clinical Trials · 5
Total integrated performance excellence system (TIPES): A true north direction for a clinical trial support center
2017 · Mike R. Sather, Sherry Parsons, et al. · Contemporary Clinical Trials Communications · 5
PDF
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
2023 · Tomas O Jensen, Greg A Grandits, et al. · The Journal of Infectious Diseases · 4
PDF
Improvements in Health‐Related Quality of Life With Treat‐to‐Target Urate‐Lowering Therapy in Gout: A Post Hoc Analysis of a Randomized Multicenter Trial
2025 · Austin Barry, Bryant R. England, et al. · Arthritis Care & Research · 3
PDF
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trial
2025 · Samantha Kohn, Harlan Sayles, et al. · Seminars in Arthritis and Rheumatism · 2
Implementation of an Online Drug–Drug Interaction Screener for the STRIVE Ensitrelvir Trial for COVID-19
2025 · Joshua P Havens, Nayon Kang, et al. · Open Forum Infectious Diseases · 1
PDF
Quality of Life assessment among participants with recurrent Clostridioides difficile infection treated with fecal microbiota transplantation versus placebo in a randomized clinical trial
2026 · Aasma Shaukat, Yuan Huang, et al. · Research Square
PDF
Efficacy and Safety of Fecal Microbiota Transplant for Prevention of Recurrent Clostridioides difficile Infection
2025 · Aasma Shaukat, Dimitri M Drekonja, et al. · Clinical Infectious Diseases
SARS-Cov-2 vaccination strategies in hospitalized recovered COVID-19 patients: a randomized clinical trial (VATICO Trial)
2025 · Sofía Sábato, Susana Benet, et al. · Scientific Reports
Efficacy and Safety of Urate Lowering Therapy (ULT) in CKD Patients With Gout
2022 · Lindsay N. Helget, Anne Davis-Karim, et al. · Journal of the American Society of Nephrology
Works count: 26
Citation count: 1,439
H-index: 15
I10-index: 16
Year
Topic
Type